LifeStance Health Group (NASDAQ:LFST) Shares Gap Down to $8.54

LifeStance Health Group, Inc. (NASDAQ:LFSTGet Rating)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $8.54, but opened at $8.26. LifeStance Health Group shares last traded at $8.32, with a volume of 66,731 shares.

Wall Street Analysts Forecast Growth

Separately, TD Cowen lowered LifeStance Health Group from an “outperform” rating to a “market perform” rating and increased their price objective for the company from $8.00 to $9.00 in a report on Monday. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, LifeStance Health Group presently has an average rating of “Moderate Buy” and an average price target of $8.04.

LifeStance Health Group Stock Performance

The company has a debt-to-equity ratio of 0.15, a current ratio of 1.17 and a quick ratio of 1.17. The business has a 50 day moving average price of $7.46 and a 200 day moving average price of $6.07.

LifeStance Health Group (NASDAQ:LFSTGet Rating) last issued its quarterly earnings results on Wednesday, May 10th. The company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.02. LifeStance Health Group had a negative return on equity of 12.32% and a negative net margin of 20.63%. The company had revenue of $252.59 million for the quarter, compared to the consensus estimate of $246.04 million. Analysts anticipate that LifeStance Health Group, Inc. will post -0.29 EPS for the current year.

Insider Activity at LifeStance Health Group

In other news, insider Kevin Michael Mullins sold 97,266 shares of the company’s stock in a transaction dated Monday, April 3rd. The shares were sold at an average price of $7.43, for a total transaction of $722,686.38. Following the completion of the transaction, the insider now owns 5,512,581 shares of the company’s stock, valued at $40,958,476.83. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold a total of 264,066 shares of company stock worth $1,744,368 in the last ninety days. 8.50% of the stock is currently owned by insiders.

Institutional Trading of LifeStance Health Group

A number of institutional investors and hedge funds have recently modified their holdings of the company. OLD National Bancorp IN bought a new position in LifeStance Health Group in the fourth quarter worth $49,000. Ameritas Investment Partners Inc. lifted its holdings in shares of LifeStance Health Group by 56.6% during the 1st quarter. Ameritas Investment Partners Inc. now owns 5,575 shares of the company’s stock worth $56,000 after acquiring an additional 2,016 shares during the period. Dynamic Advisor Solutions LLC acquired a new stake in shares of LifeStance Health Group during the 4th quarter valued at about $56,000. Squarepoint Ops LLC bought a new stake in LifeStance Health Group in the fourth quarter valued at about $62,000. Finally, Point72 Hong Kong Ltd bought a new stake in LifeStance Health Group in the second quarter valued at about $63,000. 76.49% of the stock is currently owned by institutional investors.

About LifeStance Health Group

(Get Rating)

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Featured Stories

Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with's FREE daily email newsletter.